BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/30/2023 1:19:28 PM | Browse: 380 | Download: 912
 |
Received |
|
2022-09-02 15:22 |
 |
Peer-Review Started |
|
2022-09-02 15:26 |
 |
First Decision by Editorial Office Director |
|
2023-01-05 07:48 |
 |
Return for Revision |
|
2023-01-05 07:48 |
 |
Revised |
|
2023-01-20 15:26 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2023-03-08 03:01 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2023-03-09 07:15 |
 |
Articles in Press |
|
2023-03-09 07:15 |
 |
Edit the Manuscript by Language Editor |
|
2023-02-14 02:13 |
 |
Typeset the Manuscript |
|
2023-03-19 12:16 |
 |
Publish the Manuscript Online |
|
2023-03-30 13:19 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mai Hashem and Mohamed El-Kassas |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed El-Kassas, MD, Professor, Endemic Medicine Department, Faculty of Medicine, Helwan University, Ain Helwan, Helwan, Cairo 11795, Egypt. m_elkassas@hq.helwan.edu.eg |
| Key Words |
COVID-19; Liver transplantation; Recipient; Protocols; Outcomes |
| Core Tip |
Liver transplant (LT) patients infected with severe acute respiratory syndrome coronavirus 2 have clinical, biochemical, and radiological features highly comparable to those of immunocompetent patients, except for a higher incidence of gastrointestinal symptoms. The prognosis of LT recipients is similar to non-LT patients and is not significantly affected by immunosuppression but rather by comorbidities. Considering the risk of organ rejection, it may not be wise to stop all immunosuppression after a coronavirus disease 2019 diagnosis. All LT recipients should be vaccinated, considering booster doses augment vaccination immunogenicity. Still, a considerable proportion of patients remain at risk for coronavirus disease 2019. Therefore, social isolation and other precautions must be maintained. |
| Publish Date |
2023-03-30 13:19 |
| Citation |
Hashem M, El-Kassas M. Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19. World J Clin Cases 2023; 11(10): 2140-2159 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i10/2140.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i10.2140 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.